The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis
Open accessAbstract
SUMMARY: Aim : To investigate the effect of the eradication of Helicobacter pylori on histological gastritis. Methods : Twenty‐six patients with moderate to severe atrophy received successful eradication therapy of H.pylori. Four patients dropped out and 22 were followed up prospectively for 5 years. The grades of gastritis were estimated from gastric biopsy specimens. The grade of intestinal metaplasia was also evaluated by dye‐endoscopy using methylene blue (methylthioninium chloride). The serum levels of pepsinogen, gastrin and anti‐parietal cell antibody were also determined. Results : The grades of atrophy decreased in patients with successful eradication therapy in the gastric corpus (before vs. 5 years after eradication, 2.09 ± 0.15 vs. 0.91 ± 0.17; P < 0.01) and in the antrum (2.14 ± 0.17 vs. 1.36 ± 0.17; P < 0.01). The levels of intestinal metaplasia were also decreased in the corpus (0.91 ± 0.24 vs. 0.50 ± 0.16; P < 0.05) and in the antrum (1.41 ± 0.20 vs. 1.00 ± 0.16; P < 0.05), which was also demonstrated by the methylene blue (methylthioninium chloride) staining method (33.4 ± 8.2% vs. 23.0 ± 6.5%; P < 0.05). The improvement of corpus atrophy correlated well with the high serum level of pepsinogen I (P = 0.005), but showed no correlation with the levels of anti‐parietal cell antibody. Conclusions : These results suggest that gastric atrophy and intestinal metaplasia are reversible events in some patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology
Samloff, I. M., Varis, K., Ihamaki, T., Siurala, M., & Rotter, J. I. (1982) · Gastroenterology · doi:10.1016/0016-5085(82)90176-7 · Cited by 414
Cited by
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
The gastric precancerous cascade
CORREA, P., & PIAZUELO, M. B. (2012) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00550.x · Cited by 848
Inflammation, atrophy, and gastric cancer
Fox, J. G., & Wang, T. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30111 · Cited by 772
You, W.-C., Brown, L. M., Zhang, L., Li, J.-Y., Jin, M.-L., Chang, Y.-S., Ma, J.-L., Pan, K.-F., Liu, W.-D., Hu, Y., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj264 · Cited by 446
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., Uemura, N., Murakami, K., Satoh, K., & Sugano, K. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2009.00738.x · Cited by 395
Metadata
- Authors
- Ito, M., Haruma, K., Kamada, T., Mihara, M., Kim, S., Kitadai, Y., Sumii, M., Tanaka, S., Yoshihara, M., & Chayama, K.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2002-08
- Volume
- 16
- Issue
- 8
- Pages
- 1449-1456
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2163792620
- Cited by
- 195
- References
- 2
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis. https://app.cochat.ai/papers/10.1046/j.1365-2036.2002.01311.x
- The paper
- Ito, M., Haruma, K., Kamada, T., Mihara, M., Kim, S., Kitadai, Y., Sumii, M., Tanaka, S., Yoshihara, M., & Chayama, K. (2002). Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2002.01311.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.